Trial Profile
Irinotecan in Treating Patients With Refractory Solid Tumors and Liver Dysfunction.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 21 Aug 2009
Price :
$35
*
At a glance
- Drugs Irinotecan (Primary)
- Indications Solid tumours
- Focus Therapeutic Use
- Sponsors Pfizer
- 21 Aug 2009 New trial record